How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

546 results for

stroke rehabilitation

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. ACC/AHA/SCAI/AMA?Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention

for Cardiovascular Angiography and Interventions, the American Medical Association–Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation and Mended Hearts Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and Mended Hearts Writing Committee Members Brahmajee K. Nallamothu, MD, MPH, FACC, FAHA, Co-Chair* Carl L. Tommaso, MD (...) . Curtis, PhD Sean O’Brien, PhD T. Bruce Ferguson, Jr., MD, FACC Paul D. Varosy, MD, FACC Gregg C. Fonarow, MD, FACC, FAHA Henry H. Ting, MD, MBA, FACC, FAHA Marjorie Funk, RN, PhD, FAHA, FAAN *ACC/AHA Representative. †Society of Cardiovascular Angiography and Interventions Representative. ‡Society of Thoracic Surgeons Representative. §American Association of Cardiovascular and Pulmonary Rehabilitation Representative. ¦ACC/AHA Task Force on Performance Measures Liaison. ¶National Heart Lung and Blood

2013 Society for Cardiovascular Angiography and Interventions

102. 2014 AHA/ACC Guideline for the Management of Patients With Non?ST-Elevation Acute Coronary Syndromes: Executive Summary

therapy, beta blockers, biomarkers, calcium channel blockers, cardiac rehabilitation, conservative management, diabetes mellitus, glycoprotein Ilb/IIIa inhibitors, heart failure, invasive strategy, lifestyle modification, myocardial infarction, nitrates, non-ST-elevation, P2Y 12 receptor inhibitor, percutaneous coronary intervention, renin-angiotensin-aldosterone inhibitors, secondary prevention, smoking cessation, statins, stent, thienopyridines, troponins, unstable angina, and weight management (...) . (Level of Evidence: C ) Class III: Harm Prasugrel should not be administered to patients with a prior history of stroke or transient ischemic attack. (Level of Evidence: B ) PCI—GP IIb/IIIa Inhibitors Class I In patients with NSTE-ACS and high-risk features (eg, elevated troponin) and not adequately pretreated with clopidogrel or ticagrelor, it is useful to administer a GP IIb/IIIa inhibitor (abciximab, double-bolus eptifibatide, or high-dose bolus tirofiban) at the time of PCI. (Level

2014 American Heart Association

103. Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling

Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling 1222 Background and Purpose—There are uncertainties surrounding the optimal management of patients with brain swelling after an ischemic stroke. Guidelines are needed on how to manage this major complication, how to provide the best comprehensive neurological and medical care, and how to best inform families facing complex decisions on surgical intervention in deteriorating patients. This scientific statement (...) addresses the early approach to the patient with a swollen ischemic stroke in a cerebral or cerebellar hemisphere. Methods—The writing group used systematic literature reviews, references to published clinical and epidemiology studies, morbidity and mortality reports, clinical and public health guidelines, authoritative statements, personal files, and expert opinion to summarize existing evidence and to indicate gaps in current knowledge. The panel reviewed the most relevant articles on adults through

2014 Congress of Neurological Surgeons

104. ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure

disease receive optimal care ( ). Table 1. ACCF/AHA Performance Measure Sets Topic Original Publication Date Partnering Organizations Status Heart failure 2005 ACC/AHA—inpatient measures Updated 2011 ACC/AHA/AMA-PCPI—outpatient measures Chronic stable coronary artery disease 2005 ACC/AHA/AMA-PCPI Updated 2011 Hypertension 2005 ACC/AHA/AMA-PCPI Updated 2011 ST-elevation and non–ST-elevation myocardial infarction 2006 ACC/AHA Updated 2008 Cardiac rehabilitation 2007 AACVPR/ACC/AHA Updated 2010 (referral (...) measures only) Atrial fibrillation 2008 ACC/AHA/AMA-PCPI Primary prevention of cardiovascular disease 2009 AHA/ACCF Peripheral artery disease 2010 ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS Percutaneous coronary intervention 2012 ACCF/AHA/SCAI/AMA-PCPI/NCQA Cardiac imaging 2012 ACCF/AHA/ACR/AMA-PCPI/NCQA AACVPR indicates American Association of Cardiovascular and Pulmonary Rehabilitation; ACC, American College of Cardiology; ACCF, American College of Cardiology Foundation; ACR, American College of Radiology

2012 American Heart Association

105. Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

Gerdes , J. William Gaynor , Kathleen A. Mussatto , Karen Uzark , Caren S. Goldberg , Walter H. JohnsonJr , Jennifer Li , Sabrina E. Smith , David C. Bellinger , and William T. Mahle and on behalf of the American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council Originally published 30 Jul 2012 Circulation. 2012;126:1143–1172 You are viewing the most recent version of this article. Previous (...) resuscitation, developmental disorder, developmental disability, developmental delay, developmental screening, fine and gross motor abnormalities, genetic disorder or syndrome, heart transplantation, mechanical support, microcephaly, neurodevelopment, neurodevelopmental outcome, periventricular leukomalacia, prematurity, prolonged hospitalization, psychological issues, psychosocial abnormalities, quality of life, seizures, stroke, transition, and adult CHD). The reference lists of identified articles were

Full Text available with Trip Pro

2012 American Heart Association

106. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models

a cardiovascular critical care perspective, acute MI and heart failure core measure sets are already benchmarked and publically reported as hospital quality measures. In addition, established continuous quality improvement efforts such as the American Heart Association's Get With The Guidelines quality program in heart failure, stroke, resuscitation, and coronary artery disease have well-developed in-hospital modules. Although these measures are condition- rather than setting-specific, a number

2012 American Heart Association

107. Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families

what is known about adult and pediatric patient and family responses to the ICD; educational and informational needs; factors associated with various responses; and educational, psychological, and rehabilitative interventions to promote adjustment to the ICD and prevent or reduce adverse psychological responses. The statement concludes with evidence-based recommendations for the multidisciplinary practice team, describes important gaps in the knowledge base, and identifies future directions

Full Text available with Trip Pro

2012 American Heart Association

108. Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection

an important option for children for whom there are few alternatives for MCS. Total Artificial Heart The earliest successes in MCS technology occurred with the total artificial heart. The original Jarvik 7–100 was used to support patients with severe HF, but its clinical application was limited by large device size and a high rate of stroke and infection. The CardioWest total artificial heart (Syncardia Systems Inc, Tucson, AZ) is an implantable, pulsatile, pneumatic pump with an external controller (...) repairs). This history must be considered when a BTT strategy is adopted. Another concern is increased sensitization to HLA antibodies from exposure to blood products at the time of MCS implantation. This can be of considerable risk for those patients with preexisting HLA antibodies and can create an obstacle for finding a suitable donor match. Complications of MCS, including infection, stroke, device failure, and thrombosis, can also affect ultimate candidacy for transplantation. Although early

2012 American Heart Association

110. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

STEMI e397 10.1. Use of Noninvasive Testing for Ischemia Before Discharge: Recommendations e397 10.2. Assessment of LV Function: Recommendation e398 10.3. Assessment of Risk for SCD: Recommendation e398 11. Posthospitalization Plan of Care e399 11.1. Posthospitalization Plan of Care: Recommendations e399 11.1.1. The Plan of Care for Patients With STEMI e399 11.1.2. Smoking Cessation e399 11.1.3. Cardiac Rehabilitation e399 11.1.4. Systems of Care to Promote Care Coordination e399 12. Unresolved (...) • Daiichi-Sankyo None None Steven M. Ettinger Penn State Heart & Vascular Institute—Professor of Medicine and Radiology None None None • Medtronic None None 4.3.1 James C. Fang University Hospitals Case Medical Center—Director, Heart Transplantation • Accorda• Novartis• Thoratec None None None • Medtronic None Francis M. Fesmire Heart Stroke Center—Director • Abbott None None None None • Plaintiff, Missed ACS, 2010 8.3 Barry A. Franklin William Beaumont

2012 American Heart Association

111. The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea Guideline

. The questions were then discussed, modi?ed, and approved by the fullguidelinepanel.Outcomesthatmightbe affected by each of the interventions were numericallyrated(from1to7)accordingto theirimportance.Theevidencewasassessed only for outcomes whose average rating fell into the “important” or “critical” categories. The primary outcomes evaluated were quality of life, mortality, weight loss, change in OSA severity, resolution of OSA, cardiovascular events or stroke, major and minor adverse events, daytime

2018 American Thoracic Society

112. Spasticity in adults: management using botulinum toxin - 2nd edition

throughout their careers. As an independent charity representing over 34,000 fellows and members worldwide, the RCP advises and works with government, patients, allied healthcare professionals and the public to improve health and healthcare. Citation for this document: Royal College of Physicians, British Society of Rehabilitation Medicine, The Chartered Society of Physiotherapy, Association of Chartered Physiotherapists in Neurology and the Royal College of Occupational Therapists. Spasticity in adults (...) 91 Mental imagery/mental rehearsal/mirror therapy 92 Summary 93 Appendix 9: Conflicts of interest 94 Appendix 10: Summary of evidence 96 © Royal College of Physicians 2018 vGuideline Development Group The Guideline Development Group comprised the following members and representation: Association of British Neurologists (ABN) Association of Chartered Physiotherapists in Neurology (ACPIN) British Society of Rehabilitation Medicine (BSRM) Chartered Society of Physiotherapy (CSP) Royal College

2018 British Society of Rehabilitation Medicine

113. Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel

assessment, randomized trials of these approaches will need to be completed. Risk Assessment Is Important Much of the controversy of the new American guidelines relates to the development of the new pooled cohort equations for risk assessment. Although it is derived from several cohorts, including people of various ages, ethnicities, and geographic distribution and appropriately measures risk of hard cardiovascular end points including myocardial infarction and stroke, concern has been raised that it has (...) response to a given dose of statin; (4) it is a paradigm that people have been comfortable with; and (5) this leaves the door open for combination therapy which might still prove to be useful in subjects with aggressive atherosclerosis, or statin intolerance. In addition, this approach is similar to that put forward by the European community. x 8 European Association for Cardiovascular Prevention and Rehabilitation, Reiner, Z., Catapano, A.L. et al. ESC/EAS guidelines for the management

2014 Canadian Cardiovascular Society

114. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease

Chitra Ravishankar, MD Ricardo A. Samson, MD Ravi R. Thiagarajan, MBBS, MPH Rune Toms, MD James Tweddell, MD, FAHA Peter C. Laussen, MBBS, Co-Chair On behalf of the American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardio- vascular Surgery and Anesthe- sia; and Emergency Cardiovas- cular Care Committee Cardiopulmonary Resuscitation in Infants (...) and therefore a higher risk of anaerobic metabolism. 18 The risk of inadequate cardiac output is increased in the early postoperative period and during periods of increased oxygen demand, such as from agitation, fever, inflammation, and pain. Post- operative ischemia-reperfusion injury and mural edema can reduce diastolic and systolic function and stroke volume, resulting in heart rate and preload dependence and risk of rapid deterioration. Inadequate cardiac output can be detected by close observation

Full Text available with Trip Pro

2018 American Heart Association

115. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association

screening approach for the detection of peripheral artery disease in South Asian populations in Sri Lanka, Singapore, and Pakistan. Ankle-brachial index screening of Asian populations in Singapore revealed that peripheral artery disease was more prevalent among the Indian and Malay subgroups. Stroke Major federal surveys have only recently started classifying Asian Americans into subgroups, including Asian Indians (South Asians). As a result, population-specific data for diseases such as stroke, heart

Full Text available with Trip Pro

2018 American Heart Association

116. Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologi

gaps in women. We now know that 90% of women have at least 1 risk factor for developing heart disease and that optimal prevention strategies (eg, the AHA’s Life’s Simple 7) begin decades before clinical heart disease is apparent. For these and many other reasons, a partnership with an OB/GYN to optimize early identification and modification of risk factors for heart disease and stroke can be a critical element in improving women’s health. Current State of Care for Women Traditional Cardiovascular (...) more for women (45.2%) than men (28.8%). Cardiovascular risk for women who smoke is 25% greater than for male smokers, and smoking is one of the strongest risk factors for ASCVD. In addition, cigarette use combined with oral contraceptives increases the risk of stroke, and smoking is more prevalent among younger women than younger men, with 16.7% of US women being smokers. Physical inactivity is the most prevalent risk factor for women in that one fourth of US women report no regular physical

Full Text available with Trip Pro

2018 American Heart Association

117. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association

to reduce CVD risk and to improve secondary prevention. For example, limited health literacy may be 1 factor that influences dropout rates in cardiac rehabilitation. Individuals with limited health literacy may experience barriers to referral to, engagement with, and participation in cardiac rehabilitation services and thus miss the physiological and nonphysiological benefits after coronary events. Congestive Heart Failure and Health Literacy Limited health literacy is highly prevalent in individuals

Full Text available with Trip Pro

2018 American Heart Association

118. Cardiovascular Disease Risk: Screening With Electrocardiography

, including unnecessary radiation exposure. Two studies of asymptomatic adults with diabetes reported that 6% and 12% of patients who were screened with exercise ECG subsequently underwent angiography, and 3% to 5% underwent revascularization, without evidence of benefit to the study patients. , Angiography and revascularization are associated with harms, including bleeding, contrast-induced nephropathy, cardiac arrhythmia, stroke, myocardial infarction, coronary artery dissection, allergic reaction (...) %). Based on large population-based registries that include symptomatic persons, angiography is associated with a serious harm rate of 1.7%, including arrhythmia (0.40%), death (0.10%), stroke (0.07%), and myocardial infarction (0.05%). Revascularization increases the risk of periprocedural myocardial infarction (1.7%), coronary artery dissection (1.3%), bleeding events within 72 hours (1.3%), vascular complications (0.4%), renal failure (0.4%), stroke (0.1%), and death on day of procedure (<0.01

2018 U.S. Preventive Services Task Force

119. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

recommend a formal audiometric evaluation every 5 years regardless of the initial age at diagnosis, initial hearing threshold levels, karyotype and/or presence of a mid-frequency sensorineural hearing loss, to assure early and adequate technical and other rehabilitative measures (⨁⨁◯◯). R 6.2. We recommend aggressive treatment of middle-ear disease and otitis media (OM) with antibiotics and placement of myringotomy tubes as indicated (⨁⨁◯◯). R 6.3. We recommend screening for hypothyroidism at diagnosis

Full Text available with Trip Pro

2016 European Society of Human Reproduction and Embryology

120. Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines

Pneumonectomy planned 1.5 Classgroupings A0 B 1–1.5 C 2–2.5 D >2.5 Ischaemic heart disease: history of myocardial infarction, history of posi- tive exercise test, current complaint of chest pain (myocardial ischae- mia), nitrate therapy, ECG with pathological Q waves. Cerebrovascular disease: transient ischaemic attack, stroke. ECG, electrocardiogram. Annals of Oncology Clinical Practice Guidelines Volume 28 | Supplement 4 | August 2017 doi:10.1093/annonc/mdx222 | iv9Systemictherapy In a period of about two (...) with ongoing cardiac care Institute any needed new medical interventions (i.e. beta-blockers, anticoagulants or statins) Cardiac consulation with non-invasive cardiac testing treatments as per AHA/ACC guidelines No History Physical examination Baseline ECG Calculate RCRI *RCRI weighted factors [138]: ? High risk surgery (including lobectomy or pneumonectomy) ? Ischaemic heart disease (prior myocardial infarction, angina pectoris) ? Heart failure ? Insulin-dependent diabetes ? Previous stroke or TIA

2017 European Society for Medical Oncology


Guidelines – filter by country